A5103176141- Monoclonal and Polyclonal Antibodies Research
- HER2/EGFR in Cancer Research
- Breast Cancer Treatment Studies
- Toxin Mechanisms and Immunotoxins
- Ovarian cancer diagnosis and treatment
- Cell death mechanisms and regulation
- Heat shock proteins research
- Glycosylation and Glycoproteins Research
- Cutaneous Melanoma Detection and Management
- Medical Imaging and Pathology Studies
- Mitochondrial Function and Pathology
- Endoplasmic Reticulum Stress and Disease
- Melanoma and MAPK Pathways
- Advanced MRI Techniques and Applications
- Genetic factors in colorectal cancer
- Cerebrovascular and Carotid Artery Diseases
- Functional Brain Connectivity Studies
- Proteoglycans and glycosaminoglycans research
- Bioactive Compounds and Antitumor Agents
- Radiopharmaceutical Chemistry and Applications
- Breast Lesions and Carcinomas
- Cancer Cells and Metastasis
- RNA modifications and cancer
- Tracheal and airway disorders
- Cytokine Signaling Pathways and Interactions
Cornell University
2024
University of Göttingen
1992-1996
Universitätsmedizin Göttingen
1993
University of Freiburg
1992
Zimmer Biomet (Germany)
1992
Friedrich-Alexander-Universität Erlangen-Nürnberg
1992
University of Pennsylvania
1991
Fox Chase Cancer Center
1991
Memorial Sloan Kettering Cancer Center
1991
To date, there are no prognostic factors in ovarian cancer that adequately account for tumor biology and disease behavior. In recent years, some reports have described the significance of amplification overexpression oncogene c-erb B2 various human cancers. Concerning cancer, this is still a matter discussion. present study, tissue 275 patients treated at Department Obstetrics Gynecology University Gottingen between 1982 1992 was immunohistochemically analyzed B2− encoded transmembrane...
The role of the nm23 gene in human ovarian cancer is still controversial. We studied expression nm23-H1 247 epithelial carcinomas. patients were followed-up until their death, or for a minimum 5 years if they survived. was by means immunohistochemistry and semiquantitative scoring system considering staining intensity number reactive tumour cells. Patients carrying tumours with higher scores (4–6 on scale from 0 to 6) had significantly lower survival (P = 0.01) than rest. Further stratified...
<h3>SUMMARY:</h3> The clinical standard of care in the diagnosis neurodegenerative diseases relies on [<sup>18</sup>F] FDG-PET/CT or PET MR imaging. Limitations FDG-PET include cost, need for IV access, radiation exposure, and availability. Arterial spin-labeling imaging has been shown research settings to be useful as a proxy differentiating Alzheimer disease from frontotemporal dementia. However, it is not yet widely used practice, except cerebrovascular disease. Here, we present 7...